Genotype-controlled analysis of plasma dopamine β-hydroxylase activity in psychotic unipolar major depression

Abstract

Background: Plasma activity of dopamine β-hydroxylase (DβH), the enzyme that converts dopamine to norepinephrine, is reportedly lower in patients with unipolar major depression with psychotic features (UDPF) than in those with nonpsychotic unipolar major depression (UD). Plasma DβH is under genetic control by the structural locus encoding DβH protein, DBH. This study tested the hypothesis that diagnosis-specific allelic variation at DBH accounts for lower plasma DβH in UDPF. Methods: Plasma DβH activity was measured in samples from patients with UDPF ( n = 33) and UD ( n = 45). Genotypes were determined at several functional DBH polymorphisms, including C-1021T, a single nucleotide polymorphism (SNP) in the proximal 5′ region that associates with variation in plasma DβH activity. Results: Mean plasma DβH activity was significantly lower in UDPF than in UD. Genotyping at DBH did not reveal genetic associations distinguishing UDPF from UD. A two-way analysis of variance showed significant effects of genotype and diagnostic group but no significant interaction. Conclusions: Although the effects of the diagnosis of UDPF, and of DBH allele status, on plasma DβH activity were replicated, the lower plasma DβH in patients with UDPF was not accounted for by DBH genotype. Several explanations for this result are possible. First, other variants at DBH, or at other loci, could account for the findings. Second, nongenetic factors could account for the differences in plasma DβH. In this regard, we hypothesize that abnormal regulation of hypothalamic-pituitary-adrenal function in UDPF lowers expression of DβH protein, which could in turn alter the ratio of dopamine and norepinephrine in noradrenergic neurons, thereby promoting development of psychotic symptoms.